Delivery Order SPE2DB20D2104-SPE2DB25FMTBF
- Not listed
- The Defense Logistics Agency awarded a $1,295.96 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count). This firm fixed-price delivery order is non-competitive and will be completed by August 11, 2025, with performance originating from AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $1,782.26 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Entresto 97 mg-103 mg tablets (60-count units). This firm fixed-price delivery order, with an ultimate completion date of July 30, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The award utilized no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count) valued at $3,510.76. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is scheduled for completion by July 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this pharmaceutical supply transaction, which will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Entresto 97 mg-103 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $1,597.04. This non-set-aside award represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The ultimate completion date for...
- The Defense Logistics Agency awarded a $7,996.94 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Entresto 97 mg-103 mg tablets (180-count). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 29, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under a larger contract vehicle...
- The Defense Logistics Agency awarded a $68,784.07 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 49 mg-51 mg tablets (180-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a direct fulfillment under the company's broader pharmaceutical supply arrangements. The place of performance is AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,962.22 on August 4, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count). This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $6,313.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Entresto 97 mg-103 mg tablets (180-count package), with a completion date of July 22, 2025. This non-set-aside competitive award will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $30,541.57 on July 21, 2025, for the supply of Entresto 97 mg-103 mg tablets (60 count) under a firm fixed price contract with the Defense Logistics Agency Medical Supply Chain. This competitive award, which carries an ultimate completion date of July 22, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The company's pharmaceutical distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count supply) with a ceiling value of $51,539.65. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and represents a competitively awarded contract with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMTBFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,037.83 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's comprehensive IDC with DLA enables the delivery of a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems worldwide. This specific delivery order for Entresto, a cardiac medication, exemplifies the company's role in supplying specialized pharmaceuticals through the DLA's medical supply chain infrastructure, which is foundational to sustaining military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 8/7/25 |